Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CELG.RIthis companyBristol-Myers Squibb Company Ce	$0.15	0.02×	0.01×	0×	2.54×	291946.6%	65.9%	31.4%	14.6%	38.2%	16.6%	8783.2%	2.65×	2.53×	7.99×	1.26×	3449.7%	7	1.43	5	A+
AMGNAmgen Inc.	$463.50	22.84×	20.34×	4.79×	13.11×	92.1%	70.8%	29.1%	21.0%	89.1%	13.2%	4.6%	6.31×	2.69×	3.88×	1.14×	2.9%	8	2.44	3	B+
CVSCVS Health Corp.	$85.26	56.69×	1.34×	0.25×	18.82×	284.7%	13.8%	2.6%	0.4%	2.4%	4.7%	7.8%	1.24×	8.63×	3.33×	0.84×	3.4%	7	2.45	3	B+
GILDGilead Sciences, Inc.	$169.50	17.94×	6.73×	5.19×	12.52×	-17.4%	78.8%	39.7%	28.9%	37.5%	20.3%	6.2%	1.1×	1.28×	11.43×	1.55×	2.6%	5	3.97	1	C-
HCAHCA Healthcare, Inc.	$504.14	16.31×	-17.87×	1.42×	10.05×	-33.7%	41.5%	15.8%	9.0%	-112.6%	18.5%	7.1%	-8.33×	3.15×	5.32×	0.83×	0.6%	6	2.51	2	C+
MCKMcKesson Corporation	$1,065.05	22.45×	-49.24×	0.27×	15.55×	11.2%	3.6%	1.6%	1.2%	-219.2%	31.5%	5.1%	-3.97×	0.65×	26.13×	0.85×	0.4%	7	5.91	2	B-
Peer median	—	22.45×	1.34×	1.42×	13.11×	11.2%	41.5%	15.8%	9.0%	2.4%	18.5%	6.2%	1.1×	2.69×	5.32×	0.85×	2.6%	7	2.51	2	—